Abstract
The reversal of the new class of nonvitamin K antagonist oral anticoagulants (NOACs) is challenging in the emergent perioperative setting. This summary focuses on the reversal of NOACs, determining the emergent nature (risk analysis), and other considerations in reversal.
Original language | English (US) |
---|---|
Pages (from-to) | 1073-1080 |
Number of pages | 8 |
Journal | Surgical Clinics of North America |
Volume | 98 |
Issue number | 5 |
DOIs | |
State | Published - Oct 2018 |
Keywords
- Emergent
- Nonvitamin K antagonist oral anticoagulants
- Perioperative management
- Reversal agents
- Urgent
ASJC Scopus subject areas
- Surgery